Genetics Generation Advancement Corp operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetics Generation Advancement Corp with three other
pharmaceutical manufacturers in Asia:
Malaysian Genomics Resource Centre Berhad
sales of 26.16 million Malaysian Ringgits [US$6.30 million]
CellSource Co Ltd
(1.21 billion Japanese Yen [US$11.04 million]
of which 64%
was Regenerative Medicine Related Business), and
SLS Bio Co Ltd
based in South Korea
(6.35 billion Korean Won [US$5.34 million]
Genetics Generation Advancement Corp reported sales of 381.66 million Taiwanese Dollars (US$12.67 million)
December of 2018.
increase of 4.4%
versus 2017, when the company's sales were 365.62 million Taiwanese Dollars.
This was the fourth straight year of sales growth at Genetics Generation Advancement Corp.